EP1988893A4 - Formulation contenant de desloratadine stabilisee au moyen de cyclodextrine - Google Patents

Formulation contenant de desloratadine stabilisee au moyen de cyclodextrine

Info

Publication number
EP1988893A4
EP1988893A4 EP07733895A EP07733895A EP1988893A4 EP 1988893 A4 EP1988893 A4 EP 1988893A4 EP 07733895 A EP07733895 A EP 07733895A EP 07733895 A EP07733895 A EP 07733895A EP 1988893 A4 EP1988893 A4 EP 1988893A4
Authority
EP
European Patent Office
Prior art keywords
desloratadine
cyclodextrin
containing formulation
formulation stabilized
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07733895A
Other languages
German (de)
English (en)
Other versions
EP1988893A2 (fr
Inventor
Mathivanan Natarajan
Sreekanth Joginapalli
Praveen Reddy Billa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Pharma Ltd
Original Assignee
Orchid Chemicals and Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals and Pharmaceuticals Ltd filed Critical Orchid Chemicals and Pharmaceuticals Ltd
Publication of EP1988893A2 publication Critical patent/EP1988893A2/fr
Publication of EP1988893A4 publication Critical patent/EP1988893A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP07733895A 2006-02-22 2007-02-19 Formulation contenant de desloratadine stabilisee au moyen de cyclodextrine Withdrawn EP1988893A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN289CH2006 2006-02-22
PCT/IB2007/000385 WO2007096733A2 (fr) 2006-02-22 2007-02-19 Composition pharmaceutique orale stable

Publications (2)

Publication Number Publication Date
EP1988893A2 EP1988893A2 (fr) 2008-11-12
EP1988893A4 true EP1988893A4 (fr) 2010-05-26

Family

ID=38437741

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07733895A Withdrawn EP1988893A4 (fr) 2006-02-22 2007-02-19 Formulation contenant de desloratadine stabilisee au moyen de cyclodextrine

Country Status (2)

Country Link
EP (1) EP1988893A4 (fr)
WO (1) WO2007096733A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2269586B1 (fr) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Composition pharmaceutique comprenant du desloratadine
CN102697711B (zh) * 2012-05-24 2013-10-30 广州新济药业科技有限公司 地氯雷他定口服液体制剂及其制备方法
CN116585280B (zh) * 2023-04-25 2025-03-21 海南葫芦娃药业集团股份有限公司 一种提高地氯雷他定片质量的生产工艺

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110543A2 (fr) * 1999-12-20 2001-06-27 Schering Corporation Composition orale d' une dose pour une libération prolongée
WO2005065047A2 (fr) * 2003-12-23 2005-07-21 Sun Pharmaceutical Industries Limited Composition orale stable

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101434A2 (fr) * 2001-12-21 2003-12-11 Sampad Bhattacharya Compositions pharmaceutiques intranasales comprenant un antihistaminique et un inhibiteur de leucotrienes
DE10332314B4 (de) * 2003-07-16 2006-10-26 Infineon Technologies Ag Halbleiterspeicher mit kurzer effektiver Wortleitungszykluszeit sowie Verfahren zum Lesen von Daten aus einem derartigen Halbleiterspeicher
JP2005053825A (ja) * 2003-08-04 2005-03-03 Nidek Co Ltd 点眼点鼻用組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110543A2 (fr) * 1999-12-20 2001-06-27 Schering Corporation Composition orale d' une dose pour une libération prolongée
WO2005065047A2 (fr) * 2003-12-23 2005-07-21 Sun Pharmaceutical Industries Limited Composition orale stable

Also Published As

Publication number Publication date
WO2007096733A2 (fr) 2007-08-30
WO2007096733A3 (fr) 2007-11-08
EP1988893A2 (fr) 2008-11-12

Similar Documents

Publication Publication Date Title
GB0608098D0 (en) Formulation
IL193408A0 (en) Antibody formulation
EP2077859A4 (fr) Formulation d'anticorps
ZA201003907B (en) Antibody formulation
ZA201004439B (en) Formulation
ZA200808194B (en) Granular Formulation
IL199812A0 (en) Cyclodextrin formulations
GB0707463D0 (en) Formulation
PL1927646T3 (pl) Środek nawaniający o polepszonej trwałości
EP2028971A4 (fr) Plan de travail
IL195542A0 (en) Compositions with controlled pharmacokinetics
GB0625312D0 (en) Formulation
GB0625095D0 (en) Formulation
EP1988893A4 (fr) Formulation contenant de desloratadine stabilisee au moyen de cyclodextrine
GB0715723D0 (en) Formulation
GB0712972D0 (en) Formulation
GB0702547D0 (en) Elevation
GB0612809D0 (en) Formulation
ZA200806951B (en) Homeopathy-based formulation
GB0621209D0 (en) Fencers mate
GB0610570D0 (en) Novel formulation
GB0612607D0 (en) My active desktop
AU2006100234A4 (en) Mcode
HU0600878D0 (en) Sausage-meat with swine-bread
AU2007906803A0 (en) Anti-tagging with shared declaration

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080820

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20100423

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100901